Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/09/2008WO2008120966A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management
10/09/2008WO2008120965A1 Pharmaceutical composition comprising a combination of an anti-arthritic agent, a chondroprotective agent, and an anti-inflammatory agent
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120815A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008WO2008120813A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
10/09/2008WO2008120797A1 Ampk activator
10/09/2008WO2008120778A1 Composition for promoting ketone compound formation
10/09/2008WO2008120766A1 Analgesic composition
10/09/2008WO2008120765A1 Analgesic composition
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120724A1 Medicinal solid-dispersion preparation
10/09/2008WO2008120720A1 Dentinogenesis promoter and dentinogenic pulp-capping material
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
10/09/2008WO2008120711A1 Tamibarotene capsule preparation
10/09/2008WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation
10/09/2008WO2008120690A1 Optically active organic acid-bridged binuclear platinum (ii) complexes
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120655A1 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120617A1 Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease
10/09/2008WO2008120562A1 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
10/09/2008WO2008120548A2 Oral disintegrating tablet
10/09/2008WO2008120472A1 Prophylactic and/or therapeutic agent for hyperlipemia
10/09/2008WO2008120264A1 Use of misoprostol for the topic treatment of skin lesions by stings and burns
10/09/2008WO2008120242A1 Valsartan tablet formulations
10/09/2008WO2008120241A2 Novel alcohol solvates of perindopril erbumine
10/09/2008WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008WO2008120220A1 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
10/09/2008WO2008120214A2 Compositions containing phosphatidylserine in treating diabetes associated conditions
10/09/2008WO2008120207A2 Compositions for nasal delivery
10/09/2008WO2008120131A2 Pharmaceutical compositions of diclofenac and misoprostol
10/09/2008WO2008120099A1 Thieno [3, 2-e] [1, 2] thiazine derivative as inhibitor of carbonic anhydrase
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008WO2008120004A1 Combination of a mek- inhibitor and a b-raf inhibitor for the treatment of cancer
10/09/2008WO2008120003A1 Substituted piperidines for use in the treatment of bacterial infections
10/09/2008WO2008120000A1 Therapeutic agents
10/09/2008WO2008119999A1 Therapeutic agents
10/09/2008WO2008119988A1 New combination for use in the treatment of inflammatory disorders
10/09/2008WO2008119950A1 Porphyrin compounds
10/09/2008WO2008119918A1 Mineralocorticoid receptor antagonists
10/09/2008WO2008119917A1 Quinoline derivatives as crth2 receptor ligands
10/09/2008WO2008119825A2 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119824A1 Nanoparticulate composition of chitosan and chondroitin sulfate
10/09/2008WO2008119810A2 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
10/09/2008WO2008119792A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008WO2008119790A2 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes
10/09/2008WO2008119773A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008WO2008119772A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008WO2008119771A2 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
10/09/2008WO2008119744A1 Heterocyclic spiro-compounds
10/09/2008WO2008119741A2 3-imidazolyl-indoles for the treatment of proliferative diseases
10/09/2008WO2008119721A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119720A1 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119719A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119718A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119717A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119716A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119715A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119714A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119713A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119712A1 Benzoimidazole derivatives which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119711A1 Substituted benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119689A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008WO2008119685A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119663A1 Heterocyclic antiviral compounds
10/09/2008WO2008119662A1 Non-nucleoside reverse transcriptase inhibitors
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008119618A1 Process of producing tomato paste
10/09/2008WO2008119571A2 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex
10/09/2008WO2008119544A1 Novel use of genistein
10/09/2008WO2008119543A1 Polymorph of clarithromycin (form v)
10/09/2008WO2008119534A1 Production of a viable, storable worm egg suspension
10/09/2008WO2008119518A1 Use of oligomers of lactic acid in the treatment of gynaecological disorders
10/09/2008WO2008119500A1 Methods for treating neovascular ocular diseases
10/09/2008WO2008119458A1 Substituted dibenzoic acid derivatives and use thereof
10/09/2008WO2008119260A1 A medicinal composition of carmustine, preparation method and application
10/09/2008WO2008119248A1 Photochemical reaction preparative method of four-membered ring compounds
10/09/2008WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof
10/09/2008WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
10/09/2008WO2008119176A1 Amidation process for the preparation of cathepsin k inhibitors
10/09/2008WO2008119160A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
10/09/2008WO2008119146A2 Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd
10/09/2008WO2008119109A1 Treatment of neurological disorders
10/09/2008WO2008102397A3 Colchicine derivatives, process for their preparation and use in the medical field
10/09/2008WO2008102086A3 Use of compositions containing at least one lignane and/or neolignane for modulating testosterone levels
10/09/2008WO2008101743A3 Pellets comprising an active substance matrix resistant to gastric juice
10/09/2008WO2008101052A3 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
10/09/2008WO2008100627A3 The secreted protein ccdc80 regulates adipocyte differentiation
10/09/2008WO2008100622A3 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/09/2008WO2008100130A3 Composition containing kadok extract and collagen
10/09/2008WO2008099190A3 Osteogenic compounds
10/09/2008WO2008098871A3 Use of chitosans for the treatment of nail inflammatory diseases
10/09/2008WO2008098869A3 Use of chitosans to increase nail growth rate
10/09/2008WO2008095096A9 Let-7 microrna and mimetics thereof as therapeutics for cancer